Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
11 September 2018
Congratulations UFS GradStar students
In 2018, the UFS boasts 20 students in the top 100 who were selected for the,GradStar programme, compared to last year’s five.
Every year 100 South African students are selected through a rigorous four-phase judging process to become part of the GradStar programme. The programme is designed to provide previously unrecognised students with opportunities for employment and allow them to contribute positively to South Africa’s future growth. 

UFS students improve dramatically 

The 100 students selected show the most potential as future leaders in their respective fields. Besides academic achievement, entrants are also evaluated in terms of various soft skills including motivation, discipline, altruism, and attitude. The combination of all the judgement criteria promises to deliver top candidates for future employers. In 2018, the University of the Free State (UFS) boasts 20 students in the top 100, compared to last year’s five. 

Ready to make a difference

Each student will be connected with a business mentor to further ready them for the workplace. The entire process not only prepares graduates for employment, but also provides them an opportunity for self-knowledge and recognising their own strengths and weaknesses. The top 100 will compete for a spot in the “Ten of the Finest” to be announced on 26 September 2018.

Our best wishes accompany the following UFS students in the top 100: 

Bongani Sithole: Bachelor of Science
Carlo Visser: Bachelor of Science
Christian Cookson: Bachelor of Commerce
Elsa Moitsemang: Bachelor of Commerce
Jon-Dylon Petersen: Bachelor of Science
Joseph Alappattu: Bachelor of Science
Joshua Owusu-Sekyere: Bachelor of Commerce
Josiah Meyer: Bachelor of Science
Kayurin Govender: Bachelor of Commerce
Keshalia Naidoo: Bachelor of Arts

Lise-Mari Otto: Bachelor of Education
Meredith Green: Bachelor of Laws 
Nduduzo Kubheka: Bachelor of Science
Onalenna Lephoro: Bachelor of Laws 
Razia Adriaanse: Master of Laws
Refiloe Maqelepo: Bachelor of Commerce
Sajel Singh: Bachelor of Commerce Law
Sivuyile Mpatheni: LLB
Tebello Ntene: Bachelor of Science
Tshireletso Bogatsu: Bachelor of Accounting

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept